Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer
Clinical trial NCT05965024 · RECRUITING
Trial details
- NCT number
- NCT05965024
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-10-25
- Primary completion
- 2026-08-01
- Enrollment
- 377
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.